SHANGHAI MICURX PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.5 CNY | +2.74% |
|
+1.81% | -31.09% |
| Sales 2024 * | 166M 22.92M | Sales 2025 * | 260M 35.91M | Capitalization | 2.95B 407M |
|---|---|---|---|---|---|
| Net income 2024 * | -447M -61.73M | Net income 2025 * | -467M -64.49M | EV / Sales 2024 * | 17.8 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 11.3 x |
| P/E ratio 2024 * |
-6.62
x | P/E ratio 2025 * |
-6.34
x | Employees | 205 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.36% |
More Fundamentals
* Assessed data
| 1 day | +2.74% | ||
| 1 week | +1.81% | ||
| 1 month | -11.94% | ||
| 3 months | -0.88% | ||
| 6 months | -39.76% | ||
| Current year | -31.09% |
1 week
4.28
4.52
1 month
4.285.37
Current year
3.236.77
1 year
3.239.36
3 years
3.2314.20
5 years
3.2314.20
10 years
3.2314.20
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 4.5 | +2.74% | 3,514,118 |
| 24-05-30 | 4.38 | +0.23% | 4,701,964 |
| 24-05-29 | 4.37 | -0.23% | 2,400,366 |
| 24-05-28 | 4.38 | -0.45% | 3,002,003 |
| 24-05-27 | 4.4 | -0.45% | 3,277,604 |
End-of-day quote Shanghai S.E., May 30, 2024
More quotes
Shanghai MicuRx Pharmaceutical Co Ltd is a China-based company mainly engaged in the research and development (R&D) and commercialization of innovative drugs. The Company's antibacterial drug product, contezolid tablets, can be applied to treat infections caused by multidrug-resistant gram-positive bacteria. The Company also has a number of new anti-drug-resistant bacteria, kidney cancer, nephritis drugs and anti-new crown drug pipelines in the preclinical stage, including MRX-4, MRX-5, MRX-7, MRX-15, MRX-17 and others. The Company operates its businesses primarily in the domestic market.
Sector
Pharmaceuticals
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.5
CNY
Average target price
8.55
CNY
Spread / Average Target
+90.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.09% | 407M | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 688373 Stock
